NEWS and OPINIONS

FDA Greenlights Twice-A-Year HIV Prevention Drug

FDA Greenlights Twice-A-Year HIV Prevention Drug

By Antonio Pequeño IV - Forbes - Yeztugo, a twice-a-year antiviral shot to prevent HIV, was approved by the Food and Drug Administration on Wednesday, marking a major advance in battling AIDS. Key Facts The drug (which has the generic name lenacapavir) will become...

read more
Son’s diabetes diagnosis sent scientist on quest for cure

Son’s diabetes diagnosis sent scientist on quest for cure

by Kermit Pattison - The Harvard Gazette - Decades later, Doug Melton and team are testing treatment that could make insulin shots obsolete. Doug Melton’s life irrevocably changed the day his child was diagnosed with a life-threatening disease. But unlike most other...

read more
Blocking a single enzyme rewires limb regrowth in axolotls

Blocking a single enzyme rewires limb regrowth in axolotls

By Vijay Kumar Malesu - Medical life Sciences News - In a recent study published in the journal Nature Communications, researchers in the United States explored how cytochrome P450 family 26 subfamily B member 1 (CYP26B1)-mediated retinoic acid (RA) breakdown...

read more
Stem cell therapies advance in Parkinson’s disease and beyond

Stem cell therapies advance in Parkinson’s disease and beyond

By Natalie Healey - Nature Medicine - Landmark trials using stem cells to treat Parkinson’s disease in the USA and Japan mark a turning point for cell therapy in neurodegeneration. Similar approaches to Alzheimer’s disease and amyotrophic lateral sclerosis are also...

read more
After groundbreaking CRISPR therapy, a homecoming

After groundbreaking CRISPR therapy, a homecoming

By Meghana Keshavan - Stat News - From my colleague Jason Mast: KJ Muldoon, the first infant treated with a personalized gene-editing drug, has been discharged from the hospital for the first time in his life, the Children’s Hospital of Philadelphia announced Tuesday....

read more
CAR T-Cell Therapy: New Advances Move On Past Setbacks

CAR T-Cell Therapy: New Advances Move On Past Setbacks

By Tiffany Yesavag - Genetic Bioengineering & Biotechnology News - Chimeric antigen receptor (CAR) T-cell therapy is an innovative cancer treatment that engineers a patient’s own T cells to target and destroy cancer cells. While the field has sparked significant...

read more